[Impact of high-sensitivity C-reactive protein on outcomes in patients with acute coronary syndrome undergoing drug-eluting stent implantation].

Why the study?

Does higher pre-procedural hs-CRP predict worse 2-year outcomes in Chinese NSTE-ACS patients treated with DESs?

Structured PICO

Does higher pre-procedural hs-CRP predict worse 2-year outcomes in Chinese NSTE-ACS patients treated with DESs?

P

Population

Chinese patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) treated with drug-eluting stents (DESs)

I

Intervention

Higher pre-procedural high-sensitivity C-reactive protein (hs-CRP) on admission

C

Comparator

Lower pre-procedural hs-CRP on admission

O

Outcome

2-year outcomes including major adverse cardiac and cerebrovascular events (MACCE) and revascularizationcomposite

Pre-procedural hs-CRP serves as an independent predictor of 2-year adverse cardiovascular events in NSTE-ACS patients undergoing DES implantation.

No abstract yet. The journal hasn't published one we can show.

No takes yet. Share an insight, caveat, or question.

Liu et al. (2018) studied this question.

View at Publisher

Ask AI

Bookmark

Share